Literature DB >> 10980884

Molecular genetics of hypertrophic cardiomyopathy.

J A Towbin1.   

Abstract

Hypertrophic cardiomyopathy (HCM), a serious and often tragic disorder, is characterized by hypertrophy of the interventricular septum and left ventricular wall, hypercontractile systolic function with diastolic dysfunction, and in some cases, left ventricular outflow tract obstruction. On histopathologic examination, myofiber disarray is common. The genes for familial cases of hypertrophic cardiomyopathy are known to encode members of the sarcomere and to date nine genes have been identified (beta-myosin heavy chain, alpha-tropomyosin, cardiac troponin T, troponin I, myosin binding protein-C, regulatory myosin light chain, essential myosin light chain, cardiac actin, and titin) for this genetically and clinically heterogeneous disease. In this review the genetic basis of HCM is discussed.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10980884     DOI: 10.1007/s11886-000-0010-9

Source DB:  PubMed          Journal:  Curr Cardiol Rep        ISSN: 1523-3782            Impact factor:   2.931


  52 in total

1.  Mapping a gene for familial hypertrophic cardiomyopathy to chromosome 14q1.

Authors:  J A Jarcho; W McKenna; J A Pare; S D Solomon; R F Holcombe; S Dickie; T Levi; H Donis-Keller; J G Seidman; C E Seidman
Journal:  N Engl J Med       Date:  1989-11-16       Impact factor: 91.245

Review 2.  The molecular basis for tropomyosin isoform diversity.

Authors:  J P Lees-Miller; D M Helfman
Journal:  Bioessays       Date:  1991-09       Impact factor: 4.345

Review 3.  Altered interactions among thin filament proteins modulate cardiac function.

Authors:  R J Solaro; J Van Eyk
Journal:  J Mol Cell Cardiol       Date:  1996-02       Impact factor: 5.000

4.  Dilated cardiomyopathy in homozygous myosin-binding protein-C mutant mice.

Authors:  B K McConnell; K A Jones; D Fatkin; L H Arroyo; R T Lee; O Aristizabal; D H Turnbull; D Georgakopoulos; D Kass; M Bond; H Niimura; F J Schoen; D Conner; D A Fischman; C E Seidman; J G Seidman; D H Fischman
Journal:  J Clin Invest       Date:  1999-11       Impact factor: 14.808

5.  Characteristics and prognostic implications of myosin missense mutations in familial hypertrophic cardiomyopathy.

Authors:  H Watkins; A Rosenzweig; D S Hwang; T Levi; W McKenna; C E Seidman; J G Seidman
Journal:  N Engl J Med       Date:  1992-04-23       Impact factor: 91.245

6.  Mutations in either the essential or regulatory light chains of myosin are associated with a rare myopathy in human heart and skeletal muscle.

Authors:  K Poetter; H Jiang; S Hassanzadeh; S R Master; A Chang; M C Dalakas; I Rayment; J R Sellers; L Fananapazir; N D Epstein
Journal:  Nat Genet       Date:  1996-05       Impact factor: 38.330

7.  Cardiac myosin binding protein C gene is specifically expressed in heart during murine and human development.

Authors:  F Fougerousse; A L Delezoide; M Y Fiszman; K Schwartz; J S Beckmann; L Carrier
Journal:  Circ Res       Date:  1998 Jan 9-23       Impact factor: 17.367

8.  Structural analysis of the titin gene in hypertrophic cardiomyopathy: identification of a novel disease gene.

Authors:  M Satoh; M Takahashi; T Sakamoto; M Hiroe; F Marumo; A Kimura
Journal:  Biochem Biophys Res Commun       Date:  1999-08-27       Impact factor: 3.575

9.  Angiotensin-converting enzyme polymorphism in hypertrophic cardiomyopathy and sudden cardiac death.

Authors:  A J Marian; Q T Yu; R Workman; G Greve; R Roberts
Journal:  Lancet       Date:  1993-10-30       Impact factor: 79.321

Review 10.  Familial hypertrophic cardiomyopathy: from mutations to functional defects.

Authors:  G Bonne; L Carrier; P Richard; B Hainque; K Schwartz
Journal:  Circ Res       Date:  1998-09-21       Impact factor: 17.367

View more
  9 in total

1.  LAMP2 microdeletions in patients with Danon disease.

Authors:  Zhao Yang; Birgit H Funke; Linda H Cripe; G Wesley Vick; Debora Mancini-Dinardo; Liana S Peña; Ronald J Kanter; Brenda Wong; Brandy H Westerfield; Jaquelin J Varela; Yuxin Fan; Jeffrey A Towbin; Matteo Vatta
Journal:  Circ Cardiovasc Genet       Date:  2010-02-20

2.  A novel de novo mutation of β-cardiac myosin heavy chain gene found in a twelve-year-old boy with hypertrophic cardiomyopathy.

Authors:  Seigo Okada; Yasuo Suzuki; Takuro Arimura; Akinori Kimura; Hiroko Narumi; Shunji Hasegawa
Journal:  J Genet       Date:  2014-08       Impact factor: 1.166

3.  Hypertrophic cardiomyopathy family with double-heterozygous mutations; does disease severity suggest doubleheterozygosity?

Authors:  I A W van Rijsingen; J F Hermans-van Ast; Y H J M Arens; S M Schalla; C E M de Die-Smulders; A van den Wijngaard; Y M Pinto
Journal:  Neth Heart J       Date:  2009-12       Impact factor: 2.380

4.  Decreased energetics in murine hearts bearing the R92Q mutation in cardiac troponin T.

Authors:  Maryam M Javadpour; Jil C Tardiff; Ilka Pinz; Joanne S Ingwall
Journal:  J Clin Invest       Date:  2003-09       Impact factor: 14.808

5.  Hypokinetic hypertrophic cardiomyopathy: clinical phenotype, genetics, and prognosis.

Authors:  Yishay Wasserstrum; José M Larrañaga-Moreira; Cristina Martinez-Veira; Edward Itelman; Dor Lotan; Avi Sabbag; Rafael Kuperstein; Yael Peled; Dov Freimark; Roberto Barriales-Villa; Michael Arad
Journal:  ESC Heart Fail       Date:  2022-04-30

6.  MiR-1-3p that correlates with left ventricular function of HCM can serve as a potential target and differentiate HCM from DCM.

Authors:  Mengmeng Li; Xiao Chen; Liang Chen; Kai Chen; Jianye Zhou; Jiangping Song
Journal:  J Transl Med       Date:  2018-06-09       Impact factor: 5.531

7.  Homozygous Pro1066Arg MYBPC3 Pathogenic Variant in a 26Mb Region of Homozygosity Associated with Severe Hypertrophic Cardiomyopathy in a Patient of an Apparent Non-Consanguineous Family.

Authors:  Raquel Rodríguez-López; Javier García-Planells; Marina Martínez-Matilla; Cristian Pérez-García; Amor García Banacloy; Carola Guzmán Luján; Otilia Zomeño Alcalá; Joaquina Belchi Navarro; Juan Martínez-León; Rafael Salguero-Bodes
Journal:  Life (Basel)       Date:  2022-07-12

8.  Emergence of Xin demarcates a key innovation in heart evolution.

Authors:  Shaun E Grosskurth; Debashish Bhattacharya; Qinchuan Wang; Jim Jung-Ching Lin
Journal:  PLoS One       Date:  2008-08-06       Impact factor: 3.240

9.  Temporal and morphological impact of pressure overload in transgenic FHC mice.

Authors:  Hao Chen; Hyosook Hwang; Laurel A K McKee; Jessica N Perez; Jessica A Regan; Eleni Constantopoulos; Bonnie Lafleur; John P Konhilas
Journal:  Front Physiol       Date:  2013-08-27       Impact factor: 4.566

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.